Cargando…

Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models

Recent studies suggest that infection reprograms hematopoietic stem and progenitor cells (HSPCs) to enhance innate immune responses upon secondary infectious challenge, a process called “trained immunity.” However, the specificity and cell types responsible for this response remain poorly defined. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kain, Bailee N., Tran, Brandon T., Luna, Pamela N., Cao, Ruoqiong, Le, Duy T., Florez, Marcus A., Maneix, Laure, Toups, Jack D., Morales-Mantilla, Daniel E., Koh, Scott, Han, Hyojeong, Jaksik, Roman, Huang, Yun, Catic, Andre, Shaw, Chad A., King, Katherine Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470378/
https://www.ncbi.nlm.nih.gov/pubmed/37664586
http://dx.doi.org/10.1016/j.isci.2023.107596
Descripción
Sumario:Recent studies suggest that infection reprograms hematopoietic stem and progenitor cells (HSPCs) to enhance innate immune responses upon secondary infectious challenge, a process called “trained immunity.” However, the specificity and cell types responsible for this response remain poorly defined. We established a model of trained immunity in mice in response to Mycobacterium avium infection. scRNA-seq analysis revealed that HSPCs activate interferon gamma-response genes heterogeneously upon primary challenge, while rare cell populations expand. Macrophages derived from trained HSPCs demonstrated enhanced bacterial killing and metabolism, and a single dose of recombinant interferon gamma exposure was sufficient to induce similar training. Mice transplanted with influenza-trained HSPCs displayed enhanced immunity against M. avium challenge and vice versa, demonstrating cross protection against antigenically distinct pathogens. Together, these results indicate that heterogeneous responses to infection by HSPCs can lead to long-term production of bone marrow derived macrophages with enhanced function and confer cross-protection against alternative pathogens.